JP2019504050A5 - - Google Patents

Download PDF

Info

Publication number
JP2019504050A5
JP2019504050A5 JP2018534122A JP2018534122A JP2019504050A5 JP 2019504050 A5 JP2019504050 A5 JP 2019504050A5 JP 2018534122 A JP2018534122 A JP 2018534122A JP 2018534122 A JP2018534122 A JP 2018534122A JP 2019504050 A5 JP2019504050 A5 JP 2019504050A5
Authority
JP
Japan
Prior art keywords
membered
alkyl
independently
substituted
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018534122A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019504050A (ja
JP6943859B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/066497 external-priority patent/WO2017116702A1/en
Publication of JP2019504050A publication Critical patent/JP2019504050A/ja
Publication of JP2019504050A5 publication Critical patent/JP2019504050A5/ja
Application granted granted Critical
Publication of JP6943859B2 publication Critical patent/JP6943859B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018534122A 2015-12-28 2016-12-14 駆虫性デプシペプチド化合物 Active JP6943859B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562272040P 2015-12-28 2015-12-28
US62/272,040 2015-12-28
PCT/US2016/066497 WO2017116702A1 (en) 2015-12-28 2016-12-14 Anthelmintic depsipeptide compounds

Publications (3)

Publication Number Publication Date
JP2019504050A JP2019504050A (ja) 2019-02-14
JP2019504050A5 true JP2019504050A5 (US20070167479A1-20070719-C00034.png) 2020-01-30
JP6943859B2 JP6943859B2 (ja) 2021-10-06

Family

ID=57868331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018534122A Active JP6943859B2 (ja) 2015-12-28 2016-12-14 駆虫性デプシペプチド化合物

Country Status (22)

Country Link
US (3) US10344056B2 (US20070167479A1-20070719-C00034.png)
EP (1) EP3397638B1 (US20070167479A1-20070719-C00034.png)
JP (1) JP6943859B2 (US20070167479A1-20070719-C00034.png)
KR (2) KR102427124B1 (US20070167479A1-20070719-C00034.png)
CN (1) CN108699052B (US20070167479A1-20070719-C00034.png)
AR (1) AR107249A1 (US20070167479A1-20070719-C00034.png)
AU (2) AU2016380868B2 (US20070167479A1-20070719-C00034.png)
BR (1) BR112018013369A2 (US20070167479A1-20070719-C00034.png)
CA (1) CA3009867C (US20070167479A1-20070719-C00034.png)
CL (1) CL2018001744A1 (US20070167479A1-20070719-C00034.png)
CO (1) CO2018006527A2 (US20070167479A1-20070719-C00034.png)
HK (1) HK1255391A1 (US20070167479A1-20070719-C00034.png)
IL (1) IL260262B2 (US20070167479A1-20070719-C00034.png)
MX (1) MX2018007948A (US20070167479A1-20070719-C00034.png)
MY (1) MY194716A (US20070167479A1-20070719-C00034.png)
NZ (1) NZ743913A (US20070167479A1-20070719-C00034.png)
PH (1) PH12018501367A1 (US20070167479A1-20070719-C00034.png)
RU (2) RU2715556C2 (US20070167479A1-20070719-C00034.png)
SG (1) SG11201805368YA (US20070167479A1-20070719-C00034.png)
TW (1) TWI787165B (US20070167479A1-20070719-C00034.png)
UY (1) UY37050A (US20070167479A1-20070719-C00034.png)
WO (1) WO2017116702A1 (US20070167479A1-20070719-C00034.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017024773A2 (pt) * 2015-05-20 2018-11-06 Merial, Inc. compostos depsipeptídeos anti-helmínticos
CA3009867C (en) 2015-12-28 2022-05-31 Merial, Inc. Anthelmintic cyclic depsipeptide compounds
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
AU2018219273B2 (en) 2017-02-08 2023-08-17 Boehringer Ingelheim Animal Health USA Inc. In vivo model for parasitic worm infection and methods for evaluating antiparasitic compounds, including compounds active against canine heartworm
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
MX2020004702A (es) * 2017-11-07 2020-11-06 Bayer Animal Health Gmbh Metodo para la sintesis de depsipeptidos ciclicos.
US11331369B2 (en) * 2017-11-29 2022-05-17 Zoetis Services Llc Endoparasitic depsipeptides
WO2019157241A1 (en) 2018-02-08 2019-08-15 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
AU2020205960B2 (en) 2019-01-10 2024-04-18 Zoetis Services Llc Anthelmintic laboratory animal model for heartworm
WO2020191091A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
BR112022024156A2 (pt) 2020-05-29 2023-02-14 Boehringer Ingelheim Animal Health Usa Inc Compostos heterocílicos antelmínticos
EP4262789A1 (en) 2020-12-21 2023-10-25 Boehringer Ingelheim Vetmedica GmbH Parasiticidal collar comprising isoxazoline compounds
US20230312207A1 (en) 2022-02-17 2023-10-05 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
JP2874342B2 (ja) 1992-03-17 1999-03-24 藤沢薬品工業株式会社 デプシペプチド誘導体,その製法およびその用途
WO1994019334A1 (en) 1993-02-19 1994-09-01 Meiji Seika Kaisha, Ltd. Pf1022 derivative, cyclic depsipeptide
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
WO1995007272A1 (en) 1993-09-06 1995-03-16 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
SE9303657D0 (sv) 1993-11-05 1993-11-05 Astra Ab Short-acting dihydropyridines
DE4400464A1 (de) 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4437198A1 (de) 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE69634961T2 (de) 1995-09-22 2006-04-20 Bayer Ag Neue zyklische depsipeptid pf1022 derivate
PT953563E (pt) 1996-10-07 2003-08-29 Fujisawa Pharmaceutical Co Processo para a preparacao de derivados de depsipeptidos e novos compostos intermediarios para essa preparacao
DE19713626A1 (de) 1997-04-02 1998-10-08 Bayer Ag Neue Thiodepsipeptide zur Bekämpfung von Endoparasiten und ein einfaches Verfahren zu ihrer Herstellung
CA2292698A1 (en) 1997-06-04 1998-12-10 Bayer Aktiengesellschaft Desoxycyclodepsipeptides and their use for combatting endoparasites
DE19811559A1 (de) 1998-03-17 1999-09-23 Bayer Ag Cyclooctadepsipeptide
DE19828043A1 (de) 1998-06-24 1999-12-30 Bayer Ag Ektoparasitizide Mittel
DE19921887A1 (de) 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19962147A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
DE19962145A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel/Depsipeptide
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
DE10104362A1 (de) 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
UY26592A1 (es) 2001-02-20 2001-09-28 Bayer Ag Agentes endoparasiticidas
US6893652B2 (en) * 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
US20040236191A1 (en) 2003-05-19 2004-11-25 Poliska Steven A. System and method for identifying and labeling livestock products, and managing data associated with those products
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE602005023371D1 (de) 2004-02-27 2010-10-21 Ic Services Verfahren und Satz zum Identifizieren von Tieren
DE102004055316A1 (de) 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
US20060202835A1 (en) 2005-02-25 2006-09-14 Osborne Industries, Inc. Dual frequency identification device
DE102008022520A1 (de) 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
DE102008030764A1 (de) 2008-06-28 2009-12-31 Bayer Animal Health Gmbh Kombination von Amidin-Derivaten mit cyclischen Depsipeptiden
DE102008031284A1 (de) 2008-07-02 2010-01-07 Bayer Schering Pharma Aktiengesellschaft Neue Bekämpfungsmöglichkeit der Giardiose
DE102008031283A1 (de) 2008-07-02 2010-01-07 Bayer Schering Pharma Aktiengesellschaft Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten
BRPI0922388A2 (pt) 2008-12-16 2019-09-24 Bayer Animal Health Gmbh "processo para a produção de depsipeptídeos cíclicos, contendo ácido láctico e ácido láctico fenílico opticamente ativos, com 24 átomos no anel com auxílio de estirpes de fungos do tipo rosellinia bem como de outras espécies das xylariacenn".
KR101002530B1 (ko) 2009-02-18 2010-12-17 삼성에스디아이 주식회사 알에프아이디 통신 장치
JP5779787B2 (ja) 2009-12-11 2015-09-16 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 真菌株から由来の新規な24員のシクロオクタデプシペプチドおよびその駆虫剤または内部寄生虫駆除剤としての使用
WO2012028556A1 (en) 2010-08-31 2012-03-08 Bayer Animal Health Gmbh Macrocyclic lactones and their use and their combinations with other active substances
WO2012065031A2 (en) 2010-11-11 2012-05-18 Mlp Technology Inc. Animal data management
US9848290B2 (en) 2011-03-10 2017-12-19 Aruba Networks, Inc. Location based computerized system and method thereof
MY175307A (en) 2011-12-21 2020-06-18 Bayer Ip Gmbh Preparations comprising amorphous emodepside
AU2013275223A1 (en) 2012-06-13 2015-01-22 Meiji Seika Pharma Co., Ltd. Novel cyclic depsipeptide derivative and pest control agent comprising same
US20140306005A1 (en) 2013-04-14 2014-10-16 Forever Yours, Inc. Method for Data Transport and Recovery of Dependent Creatures
BR112017024773A2 (pt) 2015-05-20 2018-11-06 Merial, Inc. compostos depsipeptídeos anti-helmínticos
CA3009867C (en) 2015-12-28 2022-05-31 Merial, Inc. Anthelmintic cyclic depsipeptide compounds
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds

Similar Documents

Publication Publication Date Title
JP2019504050A5 (US20070167479A1-20070719-C00034.png)
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
PH12021550310A1 (en) Novel sulfonamideurea compounds
RU2435760C2 (ru) 1н-хиназолин-2,4-дионы
MX2020011501A (es) Compuestos novedosos.
RU2017144495A (ru) Противогельминтные депсипептидные соединения
MX2018009840A (es) Sulfonilureas y compuestos relacionados y sus usos.
JP2019509276A5 (US20070167479A1-20070719-C00034.png)
WO2016161361A4 (en) Compositions and methods of targeting mutant k-ras
JP2016532715A5 (US20070167479A1-20070719-C00034.png)
PH12021551257A1 (en) Cyclic pantetheine derivatives and uses thereof
RU2008134534A (ru) 3,5-ди(арилили гетероарил)изоксазолы и 1,2,4-оксадиазолы в качестве агонистов рецентора s1p1, иммунодепрессантных и противовоспалительных агентов
JP2015514808A5 (US20070167479A1-20070719-C00034.png)
PE20170127A1 (es) Indazol-3-carboxamidas 5-sustituidas y preparacion y uso de las mismas
HRP20220899T1 (hr) Spojevi policikličkog karbamoilpiridona i njihova farmaceutska uporaba
RU2012136451A (ru) Композиции и способы улучшения активности протеасомы
RU2005110061A (ru) Замещенные пиперазины, (1,4)-диазепины и 2,5-диазабицикло(2,2,1)гептаны в качестве н1-и/или н3-антагонистов гистамина или обратных н3-антагонистов гистамина
DE60320012D1 (de) Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen
JP2009541223A5 (US20070167479A1-20070719-C00034.png)
JP2015522650A5 (US20070167479A1-20070719-C00034.png)
WO2019165043A3 (en) Indane-amines as pd-l1 antagonists
RU2014121205A (ru) Производные азолов
EA202192900A1 (ru) Модуляторы пути интегрированной реакции на стресс
RU2009123525A (ru) ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2
WO2014125408A3 (en) Substituted 1h-pyrrolopyridinone derivatives as kinase inhibitors